Literature DB >> 4105978

Azathioprine treatment in primary sclerosing cholangitis.

A Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4105978     DOI： 10.1016/s0140-6736(71)80107-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

2.  Steroid-responsive (autoimmune?) sclerosing cholangitis.

Authors:  Jasjeet S Sekhon; Raymond T Chung; Mark Epstein; Marshall M Kaplan
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  An unusual cholangitis.

Authors: 
Journal:  Br Med J       Date:  1976-11-06

Review 4.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

5.  Primary Sclerosing Cholangitis.

Authors:  Young-Mee Lee; David J. Kim
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

6.  Management Of Primary Sclerosing Cholangitis.

Authors:  Bimaljit S Sandhu; Velimir A Luketic
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-11

Review 7.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 8.  A review of the medical treatment of primary sclerosing cholangitis in the 21st century.

Authors:  Elizabeth C Goode; Simon M Rushbrook
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

Review 9.  The medical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-03-12

10.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; W Irish; J McMichael; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.